58
https://pubmed.ncbi.nlm.nih.gov/38092959
Acute myeloid leukemia (AML) with pure hyperdiploid karyotype (pHDK) has better outcomes after allogeneic hematopoietic cell transplantation (allo-HCT) compared to non-pure pHDK or other non-hyperdiploid complex karyotype AML.